Literature DB >> 9135946

Attentional functioning in children and adolescents with IDDM.

J Rovet1, M Alvarez.   

Abstract

OBJECTIVE: To determine whether specific attentional cognitive processes are disrupted in children and adolescents with IDDM. RESEARCH DESIGN AND METHODS: We tested 103 children and adolescents with IDDM and 100 healthy control subjects (age range 9.3-18.3 years) for intelligence and attention. Subjects were given multiple clinical tests of attention and a computerized vigilance test, all of which served to provide information about multiple components of attentional processing. Specific components studied were the abilities to focus, select, shift, suppress, inhibit, and sustain attention. A diabetic history was obtained for the IDDM group, and blood glucose levels were determined before and after computerized attention testing.
RESULTS: Across tests, IDDM subjects differed from control subjects only in the select component of attention, which was accounted for mainly by the poorer performance of children with early-onset diabetes (< 6 years). When subgrouped by history of seizures from hypoglycemia, those having had seizures demonstrated a lower verbal IQ and greater difficulty with select, focus, and inhibit attentional components, whereas sustain, suppress, and shift attentional components were unaffected. Correlation analyses showed that higher concurrent blood glucose levels were associated with less adequate ability to inhibit impulsive responses, whereas multiple regression analyses indicated that inhibit and focus were best predicted by onset age and concurrent blood glucose.
CONCLUSIONS: In children and adolescents with IDDM, attention is poorer in several but not all aspects of attention; these aspects are affected by a history of seizures from hypoglycemia and higher ambient blood glucose levels at time of testing. These results suggest both organizational and activational effects of diabetes on specific subcomponents of attention in diabetes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135946     DOI: 10.2337/diacare.20.5.803

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  31 in total

1.  Neurocognitive functioning in preschool-age children with type 1 diabetes mellitus.

Authors:  Anna Maria Patiño-Fernández; Alan M Delamater; E Brooks Applegate; Erika Brady; Margaret Eidson; Robin Nemery; Luis Gonzalez-Mendoza; Samuel Richton
Journal:  Pediatr Diabetes       Date:  2010-04-23       Impact factor: 4.866

Review 2.  Standards of medical care in diabetes--2012.

Authors: 
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

3.  Standards of medical care in diabetes--2011.

Authors: 
Journal:  Diabetes Care       Date:  2011-01       Impact factor: 19.112

4.  Management of Type 1 Diabetes in Older Adults.

Authors:  Ruban Dhaliwal; Ruth S Weinstock
Journal:  Diabetes Spectr       Date:  2014-02

5.  Standards of medical care in diabetes--2009.

Authors: 
Journal:  Diabetes Care       Date:  2009-01       Impact factor: 19.112

6.  Standards of medical care in diabetes--2010.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

Review 7.  Advances in childhood onset diabetes.

Authors:  J P Shield; J D Baum
Journal:  Arch Dis Child       Date:  1998-04       Impact factor: 3.791

8.  Attention Problems as a Predictor of Type 1 Diabetes Adherence and Metabolic Control Across Adolescence.

Authors:  Sara L Turner; Cynthia A Berg; Jonathan E Butner; Deborah J Wiebe
Journal:  J Pediatr Psychol       Date:  2018-01-01

Review 9.  The Relationship Between Executive Functioning, Type 1 Diabetes Self-Management Behaviors, and Glycemic Control in Adolescents and Young Adults.

Authors:  Ke Ding; Cheyenne M Reynolds; Kimberly A Driscoll; David M Janicke
Journal:  Curr Diab Rep       Date:  2021-02-22       Impact factor: 4.810

10.  A longitudinal investigation of cognitive function in children and adolescents with type 1 diabetes mellitus.

Authors:  Brenda A Kirchhoff; Dustin K Jundt; Tasha Doty; Tamara Hershey
Journal:  Pediatr Diabetes       Date:  2016-07-22       Impact factor: 4.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.